Skip to main content

Advertisement

Fig. 3 | Chinese Journal of Cancer

Fig. 3

From: New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

Fig. 3

Kaplan–Meier analysis estimated CNS relapse-free survival for the 376 patients in the R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) set stratified by independent risk factors. Renal involvement (a), bone involvement (b), and bone marrow (BM) involvement (c) were associated with short CNS relapse-free survival

Back to article page